Both in Biotechnology
enGene Therapeutics vs Black Diamond Therapeutics
Over the past year ENGN returned −76.6% and BDTX returned −54.2%; their daily moves had a correlation of 0.14.
ENGN −76.6% BDTX −54.2%Growth of $1, one year, split-adjusted
| Metric | ENGN | BDTX |
|---|---|---|
| Price | $1.62 | $1.81 |
| Market cap | $108.6M | $104.0M |
| Today | +11.72% | +3.43% |
| 1 month | −13.4% | −6.7% |
| 6 months | −79.5% | −36.9% |
| Year to date | −82.1% | −25.5% |
| 1 year | −77.5% | −53.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $241.0M | $110.5M |
| Dividend yield | — | — |
| Volatility (60d) | 57.4% | 61.5% |
| Short % of float | 3.4% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).